Kaiser Permanente Ventures
Venture Capital
Active
Oakland, United States
111
31M
64
1.41
7
0.42
27
- Stages of investment
- Areas of investment
Summary
Kaiser Permanente Ventures appeared to be the VC, which was created in 1945. The main department of described VC is located in the Oakland. The company was established in North America in United States. Kaiser Permanente Ventures appeared to be a CVC structure as part of the corporation.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Kaiser Permanente Ventures, startups are often financed by New Enterprise Associates, Delphi Ventures, Rock Health. The meaningful sponsors for the fund in investment in the same round are QuestMark Partners, New Leaf Venture Partners, MPM Capital. In the next rounds fund is usually obtained by Norwest Venture Partners, Morgenthaler Ventures, QuestMark Partners.
The fund is generally included in 2-6 deals every year. The average startup value when the investment from Kaiser Permanente Ventures is 500 millions - 1 billion dollars. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2012. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. This Kaiser Permanente Ventures works on 1 percentage points more the average amount of lead investments comparing to the other organizations.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Health Catalyst, Proteus Digital Health, Omada Health Among the most popular fund investment industries, there are Medical Device, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.
Besides them, we counted 4 critical employees of this fund in our database.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 141000000
- Fund raised date
- 2019-12-05
Analytics
- Total investments
- 111
- Lead investments
- 7
- Exits
- 27
- Rounds per year
- 1.41
- Follow on index
- 0.42
- Investments by industry
- Health Care (85)
- Medical Device (40)
- Biotechnology (27)
- Medical (27)
- Software (25) Show 74 more
- Investments by region
-
- United States (109)
- United Kingdom (2)
- Peak activity year
- 2012
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 131M
- Group Appearance index
- 0.99
- Avg. company exit year
- 13
- Avg. multiplicator
- 0.90
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Abridge | 23 Feb 2024 | Software, Health Care, Medical | Late Stage Venture | 150M | United States, Pennsylvania, Pittsburgh |
Osso VR | 24 Mar 2022 | Health Care, Hospital, Medical Device, Virtual Reality | Late Stage Venture | 66M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.